ODA 579
Alternative Names: anti-PfGARP small Molecule; ODA-579Latest Information Update: 25 Aug 2023
At a glance
- Originator Rhode Island Hospital
- Developer Ocean Biomedical; Ocean Sihoma
- Class Antiparasitics; Small molecules
- Mechanism of Action Protozoan protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Malaria